Detalhe da pesquisa
1.
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Oncology
; 101(3): 159-165, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103806
2.
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Hematol Oncol
; 40(1): 11-21, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714558
3.
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial.
Hematol Oncol
; 38(5): 715-725, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947651
4.
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(5): 649-662, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948276
5.
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
BMC Cancer
; 19(1): 902, 2019 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500588
6.
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Lancet
; 386(9998): 1049-56, 2015 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275735
7.
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Lancet Oncol
; 16(16): 1651-8, 2015 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538423
8.
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
Lancet Oncol
; 13(12): 1234-41, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153506
9.
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
Sci Rep
; 13(1): 3705, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879012
10.
Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.
J Clin Oncol
; 41(15): 2718-2723, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972491
11.
Diffusivity changes in bevacizumab-responding and -refractory meningioma.
Neuroradiology
; 59(11): 1059-1061, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28913584
12.
Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice.
Int J Mol Sci
; 13(12): 16020-45, 2012 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23443108
13.
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study.
Cancers (Basel)
; 14(4)2022 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205765
14.
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.
Swiss Med Wkly
; 150: w20256, 2020 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557428
15.
SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.
Blood Adv
; 4(6): 1082-1092, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196557
16.
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
J Clin Oncol
; 37(3): 202-212, 2019 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523719
17.
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
Cancer Res
; 65(24): 11631-8, 2005 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16357174
18.
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
J Hematol Oncol
; 10(1): 70, 2017 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302137
19.
"HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer.
Radiat Oncol
; 12(1): 183, 2017 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29162142
20.
EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
J Drug Target
; 14(4): 215-23, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16777680